Genocea Biosciences Inc. (GNCA) stock on a Wild Run as its Review Failed to Help Save from Closing Entirely
The biotechnology company, Genocea Biosciences Inc. (GNCA) has tried to develop a working drug for many years. Its efforts included drug development for herpes, pneumonia,